Clinical trials: Advanced Bladder Urothelial Carcinoma

Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

• Active, not recruiting
• Age: 18 years and older
• Phase 3
• Surgery or procedure

This phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it…

Conditions

Localized Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis and Ureter Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma

Trial name

AMBASSADOR (NCT03244384)

Testing

Biospecimen Collection, Clinical Observation, Computed Tomography

Where

914 sites in United States, Guam

Volunteers

739 people

Sponsor

National Cancer Institute (NCI)